Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 | New York, United States | Patent: 7 | ||
2 | South Korea | Patent: 6 | ||
3 | United States | Patent: 3 | ||
4 | China | Patent: 2 | ||
5 | North Carolina, United States | Patent: 1 |
Top 5 New Entrants companies in Dimethyl fumarate
by Most Patent Filing In 5 Years in the world in 2022
The Dimethyl fumarate top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filing In 5 Years Dimethyl fumarate New Entrants in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Dimethyl fumarate (DMF) is the methyl ester of fumaric acid and is named after the earth smoke plant (Fumaria officinalis). DMF combined with three other fumaric acid esters (FAEs) is solely licensed in Germany as an oral therapy for psoriasis (trade name Fumaderm®). Since 2013, it has been used to treat adults with relapsing multiple sclerosis (trade name Tecfidera®). In 2017, a new oral formulation of DMF (trade name Skilarence®) was approved by the European Medicines Agency (EMA) for use in Europe as a treatment for moderate-to-severe plaque psoriasis. DMF is thought to have immunomodulatory properties without causing significant immunosuppression.
Page generation time:
May 09 2025